We are live on ! Find out more
APVO icon

Aptevo Therapeutics

hedge funds and large institutions have $17.4M invested in Aptevo Therapeutics in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less capital invested

Capital invested by funds: $18M → $17.4M (-$665K)

Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SC
1
Sessa Capital
New York
$3.98M
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$2.19M
Fidelity Investments
3
Fidelity Investments
Massachusetts
$1.53M
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.45M
PM
5
Precept Management
Texas
$1.21M
BlackRock
6
BlackRock
New York
$946K
Millennium Management
7
Millennium Management
New York
$931K
Legal & General Group
8
Legal & General Group
United Kingdom
$815K
CL
9
CSS LLC
Illinois
$733K
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$654K
FM
11
Fondren Management
Texas
$292K
AA
12
AQR Arbitrage
Connecticut
$274K
Morgan Stanley
13
Morgan Stanley
New York
$248K
Geode Capital Management
14
Geode Capital Management
Massachusetts
$199K
Goldman Sachs
15
Goldman Sachs
New York
$192K
ECM
16
Element Capital Management
New York
$158K
SIM
17
Spark Investment Management
New York
$127K
PP
18
Paloma Partners
Connecticut
$121K
Northern Trust
19
Northern Trust
Illinois
$109K
BCM
20
Bridgeway Capital Management
Texas
$95K
LP
21
LMR Partners
United Kingdom
$95K
PPA
22
Parametric Portfolio Associates
Washington
$90K
Invesco
23
Invesco
Georgia
$84K
OAM
24
Oxford Asset Management
United Kingdom
$80K
ARTA
25
A.R.T. Advisors
New York
$72K